As digital breast tomosynthesis has become more widely integrated into clinical practice for both screening and diagnostic evaluation, the need to biopsy suspicious findings only visible on tomosynthesis has increased. Based on multiple reports, the most frequent imaging feature that presents in this way is architectural distortion, which carries a 21%-36% chance of malignancy [1e3] . Several centres have reported on the accuracy of tomosynthesis-directed needle localization and vacuum assisted biopsy for obtaining a diagnosis for these lesions [4e6] . A dedicated tomosynthesis-guided biopsy system is commercially available for 1 manufacturer (Affirm Biopsy System, Hologic Inc, Bedford, MA, USA). However, not all facilities have the resources to purchase this equipment and other companies have yet to develop reliable biopsy guidance systems. Without tomosynthesis biopsy capability, breast imagers typically rely on other modalities, such as ultrasound and magnetic resonance imaging, to identify the suspicious area and guide biopsy. However, in rare cases, an imaging correlate for the tomosynthesis-only finding may not exist on sonography or the patient might have a contraindication to magnetic resonance imaging. Therefore, although infrequent, there is a need to be able to provide timely diagnosis to patients with a suspicious imaging finding only seen on tomosynthesis in the absence of a dedicated tomosynthesisguided biopsy system.
We report our innovative approach to biopsy such lesions using a widely available coaxial biopsy system without using dedicated tomosynthesis-guided biopsy equipment. Described in detail subsequently, this approach combines principles described in 2 prior papers about coaxial mammographically guided core biopsy and computed tomographyeguided core biopsy [7, 8] . including the introducer, obturator, MR-compatible biopsy clip, and 9-gauge vacuum-assisted ATEC biopsy device, as well as the ultrasound trocar from the 9-gauge coaxial ATEC biopsy system (Hologic Inc). (B) Close-up view of the ultrasound trocar within the MR introducer, which is used for skin entry and initial positioning just proximal to the tomosynthesis target. This figure is available in colour online at http://carjonline.org/.
Materials and Methods
Without a dedicated tomosynthesis biopsy system, it is critical that no metal is within the breast during imaging as the system is unable to minimize this artifact without such software. Therefore, we utilise a combination of commercially available magnetic resonance and ultrasound biopsy equipment (ATEC Breast Biopsy System, Hologic Inc) to perform the biopsy (Figure 1 ). The coaxial system developed for vacuum-assisted magnetic resonance biopsy consists of a plastic introducer and plastic obturator, which can be used together to hold position in the breast while imaging. Because the trocar for the magnetic resonance biopsy system is too long to permit access to a breast in mammographic compression, we substitute a 9-gauge coaxial sonographic trocar in order to facilitate placement of the introducer.
Using standard needle localization technique with the patient seated in a chair, the targeted area is positioned in the window of the fenestrated compression plate (typically from lateral-medial or medial-lateral approach to facilitate placement of the vacuum-assisted biopsy device in the next step). The breast is imaged with tomosynthesis to identify the target and its depth ( Figure 2, A and B ). After usual sterile technique and 1% lidocaine for local anesthesia, the introducer or trocar is placed into the breast ( Figure 1B) . The trocar is removed and replaced with the obturator. After confirming that the introducer or obturator overlies the target by imaging with tomosynthesis ( Figure 2C) , the patient is taken out of compression, the gantry is rotated 90 (usually Figure 2 . A 69-year-old with large area of distortion on screening tomosynthesis examination. Sonographic biopsy of a presumed correlate revealed grade 2 ductal carcinoma in situ and a complex sclerosing lesion. However, on postbiopsy imaging, the ribbon clip was anterior and lateral to the area of distortion. Due to severe claustrophobia, magnetic resonance imaging could not be performed. Tomosynthesis-directed mammo-guided core biopsy was therefore undertaken. (A) Preprocedure tomosynthesis images in the lateral and craniocaudal projections demonstrate the area of architectural distortion in the central upper right breast (circle) which was targeted for tomosynthesis-directed coaxial core biopsy. Note the ribbon biopsy clip is located lateral, anterior, and inferior to the target corresponds to prior biopsy of an incorrectly presumed ultrasound correlate. (B) Lateral tomosynthesis view confirms the targeted architectural distortion within the fenestrated window. Using the alphanumeric grid, an introducer or trocar ( Figure 1B) is advanced into the breast and the trocar is replaced with the obturator. (C) Appropriate position of the introducer is confirmed with 2D and tomosynthesis imaging. (D) The breast is then compressed in the craniocaudal projection and 2D and tomosynthesis views are acquired to confirm that the end of the introducer lies just proximal to the targeted architectural distortion (circle). (E) Biopsies are then obtained using the 9-gauge vacuum-assisted ATEC device ( Figure 1 ) and immediate postbiopsy imaging demonstrating biopsy site changes is acquired. Subsequently, the clip is deployed through the introducer (Figure 1 ). The breast is released from compression and hemostasis is achieved. (F) Postprocedure 2-dimensional craniocaudal (not shown) and lateral projections demonstrate a dumbbell-shaped clip and biopsy site changes in the location of the architectural distortion. RCC ¼ right craniocaudal; RLM ¼ right lateral medial. craniocaudal projection), and the breast is placed back in compression. Imaging with tomosynthesis is undertaken to confirm the depth (the tip of the introducer should be just proximal to the lesion) ( Figure 2D ). In our experience, the tip of the obturator is not visible on mammography so it is important to remember that the biopsy will be of tissue that lies 2 cm distal to the end of the introducer. The obturator is then removed and a 9-gauge vacuum assisted biopsy device is inserted (Figure 1) . Keeping the device parallel to the detector, multiple core samples are obtained by rotating the device a full 360 . The device is then removed, the obturator is repositioned, and imaging with tomosynthesis is undertaken to confirm adequate sampling ( Figure 2E ). Subsequently, a biopsy clip is deployed through the introducer, imaging with tomosynthesis confirms accurate placement, and the introducer is removed from the breast. Hemostasis is achieved and Steri-Strips (3M, St. Paul, MN, USA) are placed on the skin entry site to minimize scarring.
The patient undergoes post biopsy imaging with 2-or 3dimensional craniocaudal and lateral views of the breast ( Figure 2F ), which confirms the relationship of the biopsy marker to the tomosynthesis finding. The specimens are sent to pathology and the patient is discharged to home with standard post biopsy instructions.
Discussion
With integration of digital breast tomosynthesis into breast imaging practice, there are increasingly more situations where a tomosynthesis-only suspicious abnormality is identified. For a majority of cases, breast imagers can biopsy these lesions using a dedicated tomosynthesis-directed biopsy system either via core biopsy using vacuum assistance or via localization. Alternatively, the breast imager often can find a sonographic or magnetic resonance correlate, which can then be used as a target for biopsy. However, not all facilities have tomosynthesis-directed biopsy capabilities as this piece of equipment requires substantial financial investment which may not be justified by the overall imaging volume in a practice. In addition, some patients have contraindications to magnetic resonance imaging or may not have a sonographic correlate for the tomosynthesis finding.
The technique that we employ to biopsy these infrequent mammographically occult tomosynthesis-detected findings combines principles of the traditional coaxial mammographic core described by Whitman et al [7] in 1998 combined with existing magnetic resonance and ultrasound biopsy equipment. This technique allows accurate placement of the needle and coupling with vacuum assistance permits adequate sampling. This approach only requires a standard mammographic machine with 3D capabilities. Tomosynthesis is used to guide the biopsy, as the target is not visible on any other modality. The only potential limitations of this technique might be lesions that are located too posterior such that the target can not be positioned in the fenestrated window or lesions that are too superficial that would preclude use of a vacuum-assisted device.
Based on the literature, many of the findings that are mammographically occult to conventional imaging are architectural distortions, which carries a relatively high chance of malignancy. For the instances where no sonographic or magnetic resonance correlate exists, this simple technique provides a reliable method by which a tissue diagnosis may be obtained.
